FREQ - Frequency Therapeutics EPS misses by $0.02 beats on revenue March, 29 2021 04:24 PM Frequency Therapeutics Inc. Frequency Therapeutics (FREQ): Q4 GAAP EPS of -$0.30 misses by $0.02.Revenue of $9.95M (+111.3% Y/Y) beats by $1.6M.Press Release For further details see: Frequency Therapeutics EPS misses by $0.02, beats on revenue